Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers

NCT01001988 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

596

Enrollment

INDUSTRY

Sponsor class

Conditions

Encephalitis
Japanese Encephalitis

Interventions

OTHER: Blood sample
BIOLOGICAL: JE-CV administered in Study JEC02

Sponsor

Sanofi Pasteur, a Sanofi Company